RCTs | Vaccines for Zaire Ebola virus disease.

Randomized Trial of Vaccines for Zaire Ebola Virus Disease – New England Journal of Medicine (link to abstract – $ for full-text)

News Release: Ebola vaccine regimens safe, immunogenic in adults and children – NIH News Releases

Commentaries: 

Ebola vaccine strategies show safety and immune response – CIDRAP

Trial on safety and immunogenicity of Ebola vaccines yields promising results – Institut National de la Sante et de la Recherche Medicale

Commentary on Twitter

In two randomized trials of Ebola vaccines, safety and immune responses in adults and children were assessed for three regimens with two different vaccines. All three induced immune responses lasting at least 1 year. https://t.co/JUMN8Ieygv pic.twitter.com/NajlnA2B7y

— NEJM (@NEJM) December 14, 2022